Katayama S, Kito S, Miyoshi R, Matsubayashi H
Third Department of Internal Medicine, Hiroshima University School of Medicine, Japan.
Brain Res. 1987 Sep 29;422(1):168-71. doi: 10.1016/0006-8993(87)90553-1.
The effects of several calcium antagonists, including nicardipine, nifedipine, verapamil, and diltiazem, on muscarinic acetylcholine antagonist binding were studied in the P2 fraction of the rat cerebral cortex using either [3H]quinuclidinyl benzilate ([3H]QNB) or [3H]pirenzipine as the radioactive ligand. (1) The potency of [3H]QNB binding inhibition was in the order nicardipine greater than verapamil greater than diltiazem greater than nifedipine. The IC50 values of nicardipine, verapamil, and diltiazem were 2.56 X 10(-6) M, 1.28 X 10(-5) M, and 6.00 X 10(-5) M, respectively. (2) The inhibition of [3H]QNB binding by nicardipine was significantly decreased in the presence of Ca ions. (3) In saturation experiments of [3H]QNB binding in the presence of nicardipine, the Kd value appeared to be significantly affected, but the Bmax value was unchanged. This indicated that nicardipine probably inhibited [3H]QNB binding allosterically. On the other hand, (4) nicardipine inhibited [3H]pirenzipine binding completely with an IC50 value of 7.87 X 10(-7) M. It was concluded that nicardipine had an inhibitory effect on M1-receptor binding.
使用[3H]喹硫平([3H]QNB)或[3H]哌仑西平作为放射性配体,研究了几种钙拮抗剂,包括尼卡地平、硝苯地平、维拉帕米和地尔硫䓬,对大鼠大脑皮层P2组分中毒蕈碱型乙酰胆碱拮抗剂结合的影响。(1)[3H]QNB结合抑制的效力顺序为尼卡地平>维拉帕米>地尔硫䓬>硝苯地平。尼卡地平、维拉帕米和地尔硫䓬的IC50值分别为2.56×10^(-6)M、1.28×10^(-5)M和6.00×10^(-5)M。(2)在钙离子存在下,尼卡地平对[3H]QNB结合的抑制作用显著降低。(3)在尼卡地平存在下进行[3H]QNB结合的饱和实验时,Kd值似乎受到显著影响,但Bmax值不变。这表明尼卡地平可能通过变构作用抑制[3H]QNB结合。另一方面,(4)尼卡地平以7.87×10^(-7)M的IC50值完全抑制[3H]哌仑西平结合。得出的结论是,尼卡地平对M1受体结合有抑制作用。